Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Fei Y, Tsoi MF, Cheung BMY (2019) Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis
The US Food and Drug Administration (FDA) has approved the oral formulation of the GLP-1 weight-loss drug Wegovy, making it the first oral GLP-1 therapy cleared for obesity treatment ahead of rival Eli Lillys orforglipron, which is still under FDA review
Three primary ionotropic glutamate, NMDA, alpha-amino-3-hydroxy-5-methyl-4-isooxazole-propionate (AMPA), and kainate receptors [92], can trigger excitotoxic cascades
J., Dritselis, A
US$ 28.83
US$ 27.46
US$ 29.72
US$ 20.64
US$ 27.74
US$ 21.12
US$ 26.91
/assets/images/provider/photos/2333782.jpg)
US$ 28.25
